ZVRA
ZEVRA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$11.17
+8.87%Margins
Gross margin
95.2%
EBITDA margin
56.3%
EBIT margin
31.5%
Net margin
52.8%
FCF margin
25.9%
32.7%
Return on equity
24.9%
Return on assets
19.4%
Return on invested capital
0.48x
Asset turnover
$38.7M
Cash from operations
$2.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026